Literature DB >> 3197264

Reduced release of TNF and PCA from macrophages of tolerant mice.

A Haslberger1, T Sayers, H Reiter, J Chung, E Schütze.   

Abstract

An early-phase tolerance to toxic doses of lipopolysaccharide (LPS) can be induced in mice by prior administration of sublethal doses of LPS or lipid A. These tolerant mice exhibit no hypothermia on subsequent administration of LPS and can survive a challenge dose of LPS that would normally be lethal. Peritoneal exudate cells of LPS-tolerant mice synthesized significantly reduced amounts of prostaglandins and of procoagulant activity (PCA) and tumor necrosis factor (TNF) when stimulated with LPS in vitro (compared to macrophages of control animals). Tolerance induction with lipid A was somewhat less effective. A regulatory mechanism of E-series prostaglandins (PGE) might be involved in the induction of hyporesponsiveness in macrophages of tolerant mice, as the LPS-stimulated TNF release could be inhibited in a dose dependent manner by preincubation with PGE1. Since PCA and TNF are mediators that are proposed to play a very important role in the pathophysiology of septic and endotoxic shock, a reduction in the release of these mediators may be partially responsible for early-phase tolerance to LPS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197264

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  11 in total

1.  Implantation of alloplastic material increases survival of mice subsequently exposed to polymicrobial sepsis.

Authors:  Wolfram Kessler; Tobias Ebker; Pia Koerner; Christian Poetschke; Katharina Cziupka; Tobias Traeger; Alexandra Westerholt; Hendrik Mehmcke; Friederike Neher; Robert S Jack; Claus-Dieter Heidecke; Stefan Maier
Journal:  Langenbecks Arch Surg       Date:  2009-01-27       Impact factor: 3.445

2.  Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.

Authors:  J C Mathison; G D Virca; E Wolfson; P S Tobias; K Glaser; R J Ulevitch
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

3.  Unilamellar liposomes modulate secretion of tumor necrosis factor by lipopolysaccharide-stimulated macrophages.

Authors:  G F Brisseau; A Kresta; D Schouten; J M Bohnen; P N Shek; E Fok; O D Rotstein
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

4.  Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury.

Authors:  M G Caty; K S Guice; K T Oldham; D G Remick; S I Kunkel
Journal:  Ann Surg       Date:  1990-12       Impact factor: 12.969

5.  In vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction.

Authors:  S H Zuckerman; N Qureshi
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

6.  Lipopolysaccharide preconditioning induces protection against lipopolysaccharide-induced neurotoxicity in organotypic midbrain slice culture.

Authors:  Ye Ding; Liang Li
Journal:  Neurosci Bull       Date:  2008-08       Impact factor: 5.203

7.  Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression.

Authors:  S H Zuckerman; G F Evans; L D Butler
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  Suppression of the development of tumoricidal function in gamma interferon-treated human peripheral blood monocytes by lipopolysaccharide: the role of cyclooxygenase metabolites.

Authors:  E Chu; L C Casey; J E Harris; D P Braun
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

9.  Membrane potential modulates release of tumor necrosis factor in lipopolysaccharide-stimulated mouse macrophages.

Authors:  A Haslberger; C Romanin; R Koerber
Journal:  Mol Biol Cell       Date:  1992-04       Impact factor: 4.138

10.  Effects of gamma interferon on release of tumor necrosis factor alpha from lipopolysaccharide-tolerant human monocyte-derived macrophages.

Authors:  M Matic; S R Simon
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.